Heron Therapeutics Ownership | Who Owns Heron Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Heron Therapeutics Ownership Summary

Heron Therapeutics is owned by 71.13% institutional investors, 0.98% insiders, and 27.89% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 15.84% of HRTX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.07% of its assets in Heron Therapeutics shares.

HRTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Heron Therapeutics	71.13%	0.98%	27.89%
Sector	Healthcare Stocks	50.50%	12.33%	37.17%
Industry	Biotech Stocks	49.09%	12.06%	38.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Rubric capital management lp	30.05M	15.84%	$12.82M
Clearline capital lp	11.38M	6.00%	$4.86M
Vanguard group	9.82M	5.76%	$12.77M
Blackrock funding, inc. /de	10.55M	5.56%	$4.50M
Blackrock	8.33M	5.51%	$29.14M
Velan capital investment management lp	8.75M	4.62%	$3.74M
Vanguard capital management	7.78M	4.10%	$3.32M
Tejara capital	6.51M	3.43%	$2.78M
Tang capital management	6.25M	3.30%	$2.67M
Baker bros. advisors lp	4.25M	2.76%	$5.36M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Velan capital investment management lp	8.75M	2.28%	$3.74M
Tejara capital	6.51M	1.14%	$2.78M
Jw asset management	3.75M	0.50%	$1.60M
Richmond brothers	1.79M	0.40%	$764.96K
Clearline capital lp	11.38M	0.29%	$4.86M
Cm management	1.00M	0.27%	$426.80K
Congress park capital	2.02M	0.23%	$860.62K
Ajovista	19.72K	0.20%	$69.01K
Tang capital management	6.25M	0.12%	$2.67M
Rubric capital management lp	30.05M	0.12%	$12.82M

Top Buyers

Holder	Shares	% Assets	Change
Baker bros. advisors lp	4.25M	0.04%	4.25M
Marshall wace, llp	2.35M	0.00%	2.35M
Vanguard group	9.82M	0.00%	1.36M
Sixth street partners management company	1.22M	0.00%	1.22M
Blackrock	8.33M	0.00%	1.04M

Top Sellers

Holder	Shares	% Assets	Change
Adage capital partners gp	-	-	-11.19M
Orbimed advisors	-	-	-9.82M
Palisade capital management, lp	-	-	-6.14M
Point72 asset management	-	-	-4.78M
Millennium management	4.07M	0.00%	-3.56M

New Positions

Holder	Shares	% Assets	Change	Value
Baker bros. advisors lp	4.25M	0.04%	4.25M	$5.36M
Marshall wace, llp	2.35M	0.00%	2.35M	$1.01M
Sixth street partners management company	1.22M	0.00%	1.22M	$519.61K
Diadema partners lp	458.72K	0.02%	458.72K	$195.78K
Virtu financial	283.24K	0.00%	283.24K	$121.00K

Sold Out

Holder	Change
Allspring global investments	-1.00
Caitong asset management	-1.00
Sarver vrooman wealth advisors	-1.00
Toronto dominion bank	-9.00
Lindbrook capital	-16.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	168	-2.89%	134,895,286	-14.00%	71	1.04%	80	-3.61%	38	-11.63%
Mar 31, 2026	167	-4.02%	156,599,441	0.08%	93	1.11%	78	-4.88%	43	-2.27%
Dec 31, 2025	86	-50.86%	47,611,662	-68.81%	27	0.28%	36	-54.43%	18	-63.27%
Sep 30, 2025	90	-45.78%	46,256,389	-62.08%	30	0.48%	31	-63.10%	27	-18.18%
Jun 30, 2025	174	2.35%	131,460,843	5.36%	85	1.29%	87	14.47%	34	-26.09%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	4.68M	3.07%	-
Vanguard Morn Total Stk Mkt Idx Investor	5.47M	2.90%	-
Vanguard Total Stock Mkt Idx Inv	5.47M	2.90%	-
Palisade Small Cap Core Equity	4.42M	2.34%	59.93K
iShares Russell 2000 ETF	3.60M	1.91%	-64.03K
Biotech Growth Ord	2.92M	1.55%	250.60K
Franklin US Small Cap Growth Equity	1.80M	1.19%	-
Vanguard Institutional Extnd Mkt Idx Tr	2.06M	1.09%	-
Fidelity Small Cap Index	1.54M	0.81%	28.36K
iShares Russell 2000 Growth ETF	1.33M	0.70%	-12.17K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 08, 2025	Rubric Capital Management LP	-	Buy	$3.58M
Aug 08, 2025	Rubric Capital Management LP	-	Buy	-
Aug 08, 2025	Rubric Capital Management LP	-	Buy	-
Aug 08, 2025	Morgan Adam	-	Buy	$105.02K
Aug 08, 2025	Morgan Adam	-	Buy	$2.65M

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	-
2026 Q2	-	-
2026 Q1	-	-
2025 Q4	-	-
2025 Q3	5	-

HRTX Ownership FAQ

Who Owns Heron Therapeutics?

Heron Therapeutics shareholders are primarily institutional investors at 71.13%, followed by 0.98% insiders and 27.89% retail investors. The average institutional ownership in Heron Therapeutics's industry, Biotech Stocks , is 49.09%, which Heron Therapeutics exceeds.

Who owns the most shares of Heron Therapeutics?

Heron Therapeutics’s largest shareholders are Rubric capital management lp (30.05M shares, 15.84%), Clearline capital lp (11.38M shares, 6.00%), and Vanguard group (9.82M shares, 5.76%). Together, they hold 27.61% of Heron Therapeutics’s total shares outstanding.

Does Blackrock own Heron Therapeutics?

Yes, BlackRock owns 5.51% of Heron Therapeutics, totaling 8.33M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 29.14M$. In the last quarter, BlackRock increased its holdings by 1.04M shares, a 14.27% change.

Who is Heron Therapeutics’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Heron Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.28% of its assets in 8.75M Heron Therapeutics shares, valued at 3.74M$.

Who is the top mutual fund holder of Heron Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Heron Therapeutics shares, with 3.07% of its total shares outstanding invested in 4.68M Heron Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools